Search Results - "Magota, Hirotoshi"

Intravenous Infusion of Mesenchymal Stem Cells Enhances Therapeutic Efficacy of Reperfusion Therapy in Cerebral Ischemia by Kiyose, Ryo, Sasaki, Masanori, Kataoka-Sasaki, Yuko, Nakazaki, Masahito, Nagahama, Hiroshi, Magota, Hirotoshi, Oka, Shinichi, Ukai, Ryo, Takemura, Mitsuhiro, Yokoyama, Takahiro, Kocsis, Jeffery D., Honmou, Osamu

“…Reperfusion therapy is a standard therapeutic strategy for acute stroke. Non-favorable outcomes are thought to partially result from impaired microcirculatory…”
Get full text

The Impact of Purple-Flesh Potato (Solanum tuberosum L.) cv. “Shadow Queen” on Minor Health Complaints in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study by Maeda-Yamamoto, Mari, Honmou, Osamu, Sasaki, Masanori, Haseda, Akane, Kagami-Katsuyama, Hiroyo, Shoji, Toshihiko, Namioka, Ai, Namioka, Takahiro, Magota, Hirotoshi, Oka, Shinichi, Kataoka-Sasaki, Yuko, Ukai, Ryou, Takemura, Mitsuhiro, Nishihira, Jun

“…The purple-flesh potato (Solanum tuberosum L.) cultivar “Shadow Queen” (SQ) naturally contains anthocyanins. This randomized, double-blind, placebo-controlled…”
Get full text

Repeated infusion of mesenchymal stem cells maintain the condition to inhibit deteriorated motor function, leading to an extended lifespan in the SOD1G93A rat model of amyotrophic lateral sclerosis by Magota, Hirotoshi, Sasaki, Masanori, Kataoka-Sasaki, Yuko, Oka, Shinichi, Ukai, Ryo, Kiyose, Ryo, Onodera, Rie, Kocsis, Jeffery D, Honmou, Osamu

“…Amyotrophic lateral sclerosis (ALS) is a neurodegenerative fatal disorder in which motor neurons within the brain and spinal cord degenerate. A single infusion…”
Get full text

Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model by Magota, Hirotoshi, Sasaki, Masanori, Kataoka-Sasaki, Yuko, Oka, Shinichi, Ukai, Ryo, Kiyose, Ryo, Onodera, Rie, Kocsis, Jeffery D., Honmou, Osamu

“…•IV infusion of MSCs delays disease progression in ALS rats.•IV MSC infusion protected motor neuron loss in the spinal cord.•IV MSC infusion reduced Evans Blue…”
Get full text

Pharmacological Difference Between Platelet Aggregations in Cardioembolic Stroke Patients with Direct Oral Anticoagulants: A Pilot Study by Nakazaki, Masahito, Oka, Shinichi, Magota, Hirotoshi, Kiyose, Ryo, Onodera, Rie, Ukai, Ryo, Kataoka-Sasaki, Yuko, Sasaki, Masanori, Honmou, Osamu

“…•Selecting the appropriate DOAC for embolic ischemic stroke patients.•Reports on interactions between DOACs and platelet aggregation.•Dabigatran had less…”
Get full text